Key points are not available for this paper at this time.
The pharmacologic and biochemical features of cannabinoids make them candidates for antiseizure medications. At this time, anecdotes have outstripped controlled clinical trials as sources of support for their clinical value.
Friedman et al. (Thu,) studied this question.